How have BCYP shares performed in 2024?

Big Cypress Acquisition's stock was trading at $8.44 at the beginning of 2024. Since then, BCYP shares have increased by 0.0% and is now trading at $8.44. View the best growth stocks for 2024 here .

How were Big Cypress Acquisition's earnings last quarter?

Big Cypress Acquisition Corp. (OTCMKTS:BCYP) announced its earnings results on Tuesday, November, 11th. The technology company reported ($0.01) EPS for the quarter, hitting the consensus estimate of ($0.01). The technology company had revenue of $0.31 million for the quarter, compared to analyst estimates of $0.21 million.

What other stocks do shareholders of Big Cypress Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Big Cypress Acquisition investors own include Co-Diagnostics (CODX) , iBio (IBIO) , SANUWAVE Health (SNWV) , Sierra Oncology (SRRA) , Tonix Pharmaceuticals (TNXP) , Ascent Solar Technologies (ASTI) , BioRestorative Therapies (BRTX) , Digital Ally (DGLY) and FuelCell Energy (FCEL) .

How do I buy shares of Big Cypress Acquisition?

Shares of BCYP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:BCYP

Big Cypress Acquisition (BCYP) Stock Price, News & Analysis

→ He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad)

Free BCYP Stock Alerts

$8.44

-2.01 (-19.23%)

(As of 10/22/2021)

Compare

Today's Range: $8.21
▼
$12.90
50-Day Range: $8.44
▼
$8.44
52-Week Range: $8.21
▼
$12.90

Volume: 15.34 million shs
Average Volume: 160,982 shs
Market Capitalization: $124.84 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Big Cypress Acquisition alerts:

Ad Paradigm Press

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

About Big Cypress Acquisition Stock (OTCMKTS:BCYP)

Big Cypress Acquisition Corp. does not have significant operations. The company intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or similar business combination. It primarily focuses in the life science sector. The company was incorporated in 2020 and is based in Miami Beach, Florida.

BCYP Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BCYP Stock News Headlines

April 16, 2024 | americanbankingnews.com

Big Cypress Acquisition (OTCMKTS:BCYP) Share Price Crosses Above 50-Day Moving Average of $8.44

November 13, 2023 | foxnews.com

Florida men capture massive 17-foot, 200-pound invasive python in Everglades

April 20, 2024 | Porter & Company (Ad)

New York goes dark, then America.

Artificial intelligence is about to trigger a shocking new crisis in New York. Experts warn it could be “the next 9/11” and while New York will be ground zero for this looming catastrophe, it will not be the only state impacted. This crisis could affect 233 million Americans starting at any moment from now.

October 15, 2023 | thestreet.com

Solar Stock Losers in Sharp's Big U.S. Acquisition

September 10, 2023 | usatoday.com

Big 12 college football conference preview: Oklahoma, Texas ready to ride off into sunset

August 18, 2023 | finance.yahoo.com

Big Ridge Gold Completes Acquisition of Gold Island Inc. Creating a Premier Newfoundland Based Exploration Company

April 4, 2023 | forbes.com

Big Ass Fans

March 2, 2022 | reuters.com

SAB Biotherapeutics Inc

April 20, 2024 | Porter & Company (Ad)

New York goes dark, then America.

October 21, 2021 | finance.yahoo.com

Big Cypress Acquisition Corp. Stockholders Approve Business Combination with SAB Biotherapeutics

October 4, 2021 | finance.yahoo.com

SAB Biotherapeutics Announces First Patient Dosed in Phase 3 NIH ACTIV-2 Trial Evaluating SAB-185 for Treatment of COVID-19

September 28, 2021 | finance.yahoo.com

SAB Biotherapeutics Appoints Russell Beyer Chief Financial Officer

September 24, 2021 | finance.yahoo.com

SAB Biotherapeutics Announces SAB-185 Receives Positive DSMB Review and Advances to Phase 3 in NIH-Sponsored ACTIV-2 Trial for Treatment of COVID-19

September 22, 2021 | finance.yahoo.com

SAB Biotherapeutics Awarded Additional $60.5M from BARDA and U.S. Department of Defense for Rapid Response Capability and Advancing SAB-185 for Treatment of COVID-19

September 15, 2021 | finance.yahoo.com

SAB Biotherapeutics Announces Completion of Enrollment in Phase 2a Challenge Trial of SAB-176 for the Treatment of Seasonal Influenza

September 8, 2021 | finance.yahoo.com

SAB Biotherapeutics to Present at Upcoming September Virtual Investor Conferences

August 11, 2021 | barrons.com

Big Cypress Acquisition Corp.

August 11, 2021 | finance.yahoo.com

SAB Biotherapeutics Announces Nonclinical Data Demonstrating SAB-185 Potently Neutralizes Delta and Lambda SARS-CoV-2 Variants

August 10, 2021 | nasdaq.com

Big Cypress Acquisition Corp. Common stock (BCYP)

See More Headlines

Receive BCYP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Big Cypress Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/11/2014
Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biological Products, Except Diagnostic
Sub-Industry: N/A
Current Symbol: OTCMKTS:BCYP
CUSIP: N/A
CIK: 1399587
Web: www.bluecalypso.com
Phone: 305-204-3338
Fax: N/A
Employees: 5
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 6.13
Quick Ratio: 6.13

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 14,792,000
Free Float: N/A
Market Cap: $124.84 million
Optionable: Not Optionable
Beta: N/A

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Mr. Samuel J. Reich (Age 46)
CEO, CFO & Director

Key Competitors

View All Competitors

BCYP Stock Analysis - Frequently Asked Questions

How have BCYP shares performed in 2024?: Big Cypress Acquisition's stock was trading at $8.44 at the beginning of 2024. Since then, BCYP shares have increased by 0.0% and is now trading at $8.44.
View the best growth stocks for 2024 here.
How were Big Cypress Acquisition's earnings last quarter?: Big Cypress Acquisition Corp. (OTCMKTS:BCYP) announced its earnings results on Tuesday, November, 11th. The technology company reported ($0.01) EPS for the quarter, hitting the consensus estimate of ($0.01). The technology company had revenue of $0.31 million for the quarter, compared to analyst estimates of $0.21 million.
What other stocks do shareholders of Big Cypress Acquisition own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Big Cypress Acquisition investors own include Co-Diagnostics (CODX), iBio (IBIO), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Ascent Solar Technologies (ASTI), BioRestorative Therapies (BRTX), Digital Ally (DGLY) and FuelCell Energy (FCEL).
How do I buy shares of Big Cypress Acquisition?: Shares of BCYP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BCYP) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial